Sōlaria Biō
Solarea Bio, a Cambridge-based biotech firm, innovates microbiome solutions for global health issues.
- 24
- Acquired, subsidiary of Viome
- Waltham, MA, USUnited States
Solarea Bio, a Cambridge-based biotech firm, innovates microbiome solutions for global health issues.
solaria.bioCrawled Oct 29, 2026
Bōndia - 1 Year Supply - One-Time Purchase
Bōndia - 2 Month Subscription
A research study evaluates how once-daily versus twice-daily administration of SBD111 (Bōndia) affects levels in the body for participants aged 35 or older.
Osteopenia vs osteoporosis explained: DEXA T-scores, progressive fracture risk, and the prevention steps that matter most in midlife and beyond.
The page explains how plant microbes and synbiotics protect bone density and describes the gut-bone axis.
Bōndia - 3 Month Subscription
The company’s clinically backed prebiotic and probiotic blends support stronger bones with consistent use.
Solaria Bio offers clinically backed supplements, including bone health synbiotics and osteopenia solutions.
Solaria Bio provides wholesale access to its natural bone health solutions for registered businesses.
Solaria Bio’s Privacy Policy details how personal information and data are collected, used, and disclosed.
The page explains how Journa Health collects, uses, and protects personal information on its Shopify site and outlines privacy rights.
Solaria Bio’s Terms of Service outline site use, policies, and secure e-commerce practices.
The terms of service for Journa Health cover age restrictions, product information, subscriptions, and user rights.
Viome acquires **Sōlaria Biō** to expand into **clinically validated synbiotics and medical foods**, leveraging the acquired company’s expertise in gut microbiome-based products. The move aligns with Viome’s precision health focus, combining its RNA diagnostics with Sōlaria’s medical nutrition solutions. This acquisition strengthens Viome’s position in developing personalized health products for consumer and clinical markets.
Oct 2026Business WireNews article
Solarea Bio presents its edible plant microbiota research at the 2025 Future Food-Tech Summit. The company focuses on leveraging natural plant microbes to develop health-enhancing solutions. Their innovations aim to address human health challenges through biotechnology. The presentation highlights their clinical-stage progress in this emerging field.
Mar 2025PR NewswireNews article
Solarea Bio introduces a novel class of medical foods targeting age-related health conditions through natural dietary solutions. The company focuses on addressing prevalent health challenges in aging populations with scientifically formulated products. This initiative builds on advancements made in 2024, positioning Solarea Bio as a leader in medical nutrition innovation.
Feb 2025PR NewswireNews article
Solarea Bio introduces **Bondia™**, a daily medical food designed to help peri- and postmenopausal women address bone loss. The product targets a condition affecting all women in these stages, aiming to mitigate risks of osteoporosis. Bondia™ enters beta testing as a specialized nutritional intervention for bone health management.
May 2024PR NewswireNews article